Skip to main content

stock

FIXX · Q32 Bio Inc.

What Q32 Bio Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live FIXX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on FIXX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
29,769,466 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
31.9%
ROA
29.1%

Health

Current ratio
20.3x
Debt/equity
—

Deep value

NCAV
$99.68M
NCAV per share
$3.35
Price/NCAV
Locked
NNWC
$96.31M
NNWC per share
$3.24
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$9.12M-$8.95M
10-Q filed 2026-08-05
2026-03-31——Gross profit: unreported by this company.-$7.72M-$7.61M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.$45.88M$57.71M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——Gross profit: unreported by this company.-$7.58M-$7.39M
10-Q filed 2025-11-13
2025-06-30——Gross profit: unreported by this company.-$9.17M-$9.49M
10-Q filed 2026-08-05
2025-03-31——Gross profit: unreported by this company.-$12.23M-$11.03M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$14.53M-$14.16M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$18.81M-$17.59M
10-Q filed 2025-11-13
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$115.87M
Equity
$105.91M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$53.74M$16.90M$29.80M-$33.54M
2024-12-31$0-$66.10M-$47.70M-$67.79M
2023-12-31$1.16M-$48.26M-$53.70M-$18.68M
2022-12-31$3.21M-$133.28M-$5.00M-$114.95M
2021-12-31$33.97M-$95.95M-$95.76M-$112.15M
2020-12-31$2.70M-$130.26M-$128.69M-$98.06M
2019-12-31$1.67M-$109.94M-$103.92M-$113.19M
2018-12-31$5.32M-$59.93M-$55.58M-$67.50M
2017-12-31—-$29.66M-$29.99M$4.52M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named FIXX, and the market events around them.

Sign in to see this

Board

The FIXX board could not be loaded.

Retry the FIXX board

nakagai

Signals on FIXX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the FIXX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Q32 Bio Inc. (FIXX): SEC filings, financials and insider trades · Nakagai